首页> 美国卫生研究院文献>The Medical Bulletin of Sisli Etfal Hospital >Approach Toward Diabetes Treatment in the Elderly
【2h】

Approach Toward Diabetes Treatment in the Elderly

机译:老年糖尿病的治疗方法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Concomitant diseases in elderly individuals with diabetes (renal failure, heart failure, ischemic heart disease, stroke, urinary incontinence, cognitive impairment, dementia, sarcopenia, and osteoporosis) make diabetes management difficult. Therefore, other comorbid conditions should be taken into account in elderly diabetics when considering a treatment approach. The use of oral antidiabetic agents in individuals older than 75 years may be limited. Although the diabetes treatment is not any different in healthy elderly patients, hypoglycemia is one of the most feared conditions, especially in the elderly. Therefore, metformin, DPP-IV inhibitors, and SGLT2 inhibitors should be considered in the first place with less risk of hypoglycemia. Low-dose sulfonylureas may also be used in selected cases. The use of new antidiabetic drugs, such as GLP-1 anologues and SGLT2 inhibitors, has strengthened our ability to cope with the risk of hypoglycemia and cardiovascular events, which are the two most important drawbacks in the treatment of elderly people with diabetes. Insulin treatment should be individualized, and the most rare injection regimens should be used. In case of failure of OAD, basal insulin should be added to the current treatment, and if necessary, a basal + plus regimen should be planned by adding bolus insulin 1/2/3 times per day to the meals. As a result, in elderly diabetics, an inadequate treatment or excessive treatment and individualizing the treatment should be the most appropriate approach.
机译:老年糖尿病患者的伴随疾病(肾衰竭,心力衰竭,缺血性心脏病,中风,尿失禁,认知障碍,痴呆,肌肉减少症和骨质疏松症)使糖尿病治疗变得困难。因此,老年糖尿病患者在考虑治疗方法时应考虑其他合并症。在75岁以上的人群中口服抗糖尿病药的使用可能受到限制。尽管健康的老年患者对糖尿病的治疗没有什么不同,但低血糖是最令人担忧的疾病之一,尤其是在老年人中。因此,首先应考虑使用二甲双胍,DPP-IV抑制剂和SGLT2抑制剂,降低低血糖风险。在某些情况下也可使用低剂量磺酰脲类药物。使用新的抗糖尿病药物,例如GLP-1糖类似物和SGLT2抑制剂,已经增强了我们应对低血糖和心血管事件风险的能力,这是治疗老年糖尿病患者的两个最重要的缺点。胰岛素治疗应个体化,并且应使用最罕见的注射方案。如果OAD失败,则应在当前治疗中添加基础胰岛素,如有必要,应计划在餐后每天添加1/2/3次推注胰岛素,以制定基础+方案。因此,在老年糖尿病患者中,治疗不足或过度治疗以及个体化治疗应是最合适的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号